FTC review

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced after the close of the market on Wednesday a public offering of $2.2 billion of its common stock.

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said it has extended its cash tender offer to purchase Orchid Cellmark to 5 p.m. EDT Oct. 7.

LabCorp extended the offer for 30 days while the FTC continues its review of the $85.4 million acquisition.

As of May 17, Orchid shareholders had tendered and not withdrawn about 85 percent of the company's outstanding shares.

The FTC provided provisional approval of Danaher's purchase of MDS Analytical Technologies. However, it is requiring MDS to sell its laser microdissection business to Life Technologies to alleviate the agency's competition concerns.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.